Showing results (601-610 of 4,206) with videos related to
Sort By:
Pageof 421
Discover Oncology|January 28, 2025
Improving molecular subtypes and prognosis of pancreatic cancer through multi group analysis and machine learningXue-Jian Zhang, Fang-Fang Lin, Ya-Qing Wen, et al.Discover Oncology|January 31, 2025
Bioinformatics analysis combined with experimental validation reveals the biological role of the ILK gene in prostate cancerXiao-Xiang Yu, Yi Liu, Rong-Jiang Luo, et al.Discover Oncology|March 5, 2025
The interplay between angiogenesis-associated genes and molecular, clinical, and immune features in bladder cancerXiaoxiao Guo, Jingxin Yang, Rui Cao, et al.Discover Oncology|February 21, 2025
Plasma treatment can efficiently increase the attachment of pancreatic circulatory tumor cells to the surfaceSeyed Mohammad Amin Mahdian, Azam Mahmoudi-Aznaveh, Seyed Mojtaba Mousavi, et al.Discover Oncology|March 14, 2025
Efficacy and safety of immunotherapy plus chemotherapy in advanced or metastatic pulmonary large-cell neuroendocrine carcinomaRuyue Li, Huanle Zhang, Ying Li, et al.Discover Oncology|March 17, 2025
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinomaSintim Mui, Juanyi Shi, Kai Wen, et al.Discover Oncology|March 17, 2025
Pan-cancer analysis and experimental verification of cytochrome B561 as a prognostic and therapeutic biomarker in breast cancerXiaoting Qiu, Peizhang Liu, Hongxiang Lin, et al.Discover Oncology|March 15, 2025
Research trends of neoadjuvant therapy in lung cancer: a bibliometric analysisXiaoru Geng, Youqin Jiang, Yichun Zeng, et al.Discover Oncology|March 13, 2025
EXO1's pan-cancer roles: diagnostic, prognostic, and immunological analyses through bioinformaticsZheng Liu, Shu Huang, Rui Luo, et al.Discover Oncology|February 27, 2025
EFNB1 drives glioma progression and shapes the immune microenvironment: a potential prognostic biomarkerYungui Zheng, Jiasong ShiPageof 421